| RKV Stock | | | CAD 0.09 0.01 12.50% |
Rakovina Therapeutics financial indicator trend analysis is much more than just breaking down Rakovina Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rakovina Therapeutics is a good investment. Please check the relationship between Rakovina Therapeutics Intangible Assets and its Total Current Liabilities accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rakovina Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Intangible Assets vs Total Current Liabilities
Intangible Assets vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Rakovina Therapeutics Intangible Assets account and
Total Current Liabilities. At this time, the significance of the direction appears to have pay attention.
The correlation between Rakovina Therapeutics' Intangible Assets and Total Current Liabilities is -0.76. Overlapping area represents the amount of variation of Intangible Assets that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Rakovina Therapeutics, assuming nothing else is changed. The correlation between historical values of Rakovina Therapeutics' Intangible Assets and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Intangible Assets of Rakovina Therapeutics are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Intangible Assets i.e., Rakovina Therapeutics' Intangible Assets and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | -0.76 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Intangible Assets
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.
Total Current Liabilities
Total Current Liabilities is an item on Rakovina Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Rakovina Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Rakovina Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rakovina Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rakovina Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Selling General Administrative is likely to drop to about 706.8
K in 2024.
Issuance Of Capital Stock is expected to grow at the current pace this year
Rakovina Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Rakovina Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Rakovina Therapeutics fundamental ratios Accounts
| | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) |
| Retained Earnings | | (1.1M) | (13.0) | (5.5M) | (8.3M) | (10.9M) | (10.4M) |
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Rakovina Stock Analysis
When running Rakovina Therapeutics' price analysis, check to
measure Rakovina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rakovina Therapeutics is operating at the current time. Most of Rakovina Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Rakovina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rakovina Therapeutics' price. Additionally, you may evaluate how the addition of Rakovina Therapeutics to your portfolios can decrease your overall portfolio volatility.